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ABSTRACT
INTRODUCTION: Effective and timely prevention of acute ischemic stroke (AIS) is characterized by a ris-
ing socio-medical importance as this is the most common cerebrovascular disease worldwide and in Bulgar-
ia as well. Our purpose was to reveal the incidence rate of the disorders of glucose metabolism in AIS devel-
opment among adult patients.
MATERIAL AND METHODS: We examined 129 male and 129 female patients with AIS at a mean age of 
70.59±7.22 years hospitalized in the First Clinic of Neurology, St. Marina University Hospital of Varna in 
2007-2013. Blood glucose concentrations at admission were examined. Statistical data processing was per-
formed by variation (ANOVA as t-criterion was considered significant if p<0.05) and correlation (Pearson’s 
coefficient) analyses.
RESULTS: Mean fasting blood glucose levels were most commonly elevated and total ones were higher in 
males than in females except for the minimal value. The males with abnormally elevated blood glucose val-
ues present with higher mean and maximal values than the females. The number and relative share of the 
patients with increased blood glucose values at admission considerably prevailed. The difference between 
the number of the males with increased values and that of those with normal values was statistically signif-
icant (t=3.33; p<0.01). There was moderate correlation between the level of blood glucose and the preceding 
diabetes mellitus (r=0.431) and a strong one between this level and the newly-diagnosed diabetes mellitus 
(r=0.733) among our AIS patients.
CONCLUSION: The regular control of blood glucose by the general practitioners and the promotion of the 
healthy life-style in cardiovascular disease patients could successfully prevent AIS in Bulgaria.
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INTRODUCTION
Acute ischemic stroke (AIS) is the most com-
mon cerebrovascular disease worldwide and in Bul-
garia as well. The disorders of glucose metabolism 
are a recognized risk factor for AIS. Besides diabe-
tes mellitus represents an unfavourable prognos-
tic factor for AIS patients (1). Patients with diabetes 
mellitus have approximately twice the risk of AIS 
compared to those without this disease (2). Metabol-
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ic pathology in diabetes mellitus causes cerebral arte-
rial dysfunction and that is why such patients require 
proper management of any metabolic disorders in or-
der to reduce atherogenesis (3). Serial blood glucose 
measurements might be a better predictor of clinical 
outcome in AIS patients treated with intravenous 
thrombolysis than single ones before this treatment 
(4). Hyperglycaemia is a strong risk factor for poor 
outcome after AIS, but it may be simply a marker of 
poor outcome rather than a cause. Glucose lowering 
does not relate to improved prognosis of the disease. 
MATERIAL AND METHODS 
Our investigation covered 129 male and 129 fe-
male patients with AIS at a mean age of 70.59±7.22 
years hospitalized in the First Clinic of Neurology, 
St. Marina University Hospital of Varna in 2007-
2013. Fasting blood glucose concentrations at ad-
mission were examined and analyzed according to 
gender and number of accompanying cardiovascu-
lar diseases (CVDs) or pathological conditions. In 
2013, glycated hemoglobin values were estimated in 
12 AIS patients, seven males and five females, too. 
Statistical data processing was performed by varia-
tion (ANOVA as t-criterion was considered signifi-
cant if p<0.05) analysis and correlation (Pearson’s co-
efficient) analysis as well. SPSS, version 13.0 software 
was used.
RESULTS
Mean blood glucose concentrations vary in rel-
atively broad limits (between 6.14 mmol/L in 2010 
and 7.97 mmol/L in 2013) (Table 1). Total blood glu-
cose values are higher in males than in females ex-
cept for the minimal value.
The analysis of the number and relative share 
of the patients with normal, decreased and increased 
blood glucose values displays the frequency of anom-
alies and thus illustrates the importance of regular 
examinations under outpatient conditions for pre-
ventive purposes (Table 2 and Table 3). The males 
with abnormally elevated values present with high-
er mean and maximal values than the females. Be-
sides the range between the maximal concentration 
in the cases with pathologically increased blood glu-
cose values and its minimal concentration in the cas-
es with pathologically decreased blood glucose val-
ues is broader in the male than in the female patients 
(14.70 mmol/L versus 12.20 mmol/L). The number 
and relative share of the patients with elevated blood 
glucose values at admission considerably prevail. The 
difference between the number of the males with in-
Years
Blood glucose (mmol/L)
mean values minimal values maximal values
2007 6.75±2.94 4.08 18.30
2008 6.61±2.14 4.08 13.70
2009 6.87±2.51 3.70 13.00
2010 6.14±2.14 3.60 14.90
2011 6.90±2.47 3.90 14.10
2012 7.57±2.98 4.40 15.20
2013 7.97±3.07 3.70 18.00
total males 7.38±2.92 3.60 18.30
total females 6.95±2.60 4.00 16.20
total 7.16±2.77 3.60 18.30




normal values 5.16±0.45 5.11±0.45
increased values 8.91±2.81 8.49±2.60
decreased values 3.74±0.11 4.05±0.05
Table 2. AIS patients with mean normal and pathological 
blood glucose values at admission
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creased values and that of those with normal values 
is statistically significant (t=3.33; p<0.01).
The mean glycated hemoglobin value was 
6.7% (range, 5.9% and 7.2%). The small number of 
these cases did not allow any reliable statistical data 
processing. 
There is moderate positive correlation between 
the level of blood glucose and the preceding diabe-
tes mellitus (r=0.431) as well as a strong one between 
this level and the newly-diagnosed diabetes melli-
tus (r=0.733) among our AIS patients (Table 4). This 
demonstrates that the disorders of glucose metabo-
lism are associated with the occurrence of AIS, espe-
cially in males. 
The blood glucose values of AIS patients pre-
senting with at least one out of nine accompany-
ing CVDs or pathological conditions have been an-
alyzed. These nosologic units are the following: ar-
terial hypertension, hypertensive heart, coronary 
atherosclerosis, ischemic heart disease, effort an-
gina pectoris, myocardial infarction, atrial fibrilla-
tion, ventricular tachyarrhythmia, and heart failure. 
It should be noted that there is no CVD in one male 
patient at all while one female patient presents with 
eight accompanying CVDs (Table 5). The males with 
four and two other diseases each as well as the fe-
males with two and seven other diseases each present 
with the highest mean blood glucose concentrations. 
These findings support the relationship between di-
abetes mellitus and CVDs as proved risk factors for 
AIS in adulthood.
DISCUSSION
Hyperglycaemia relates to poor prognosis of 
AIS. It is an indicator of severe AIS that can’t en-
hance the glucose concentration in the brain. How-
ever, it further promotes cerebral ischemia. The ce-
rebral glucose concentration controlled by the cere-
bral glucose transporters contributes to the energy 
supply to the brain, especially among AIS patients, 
and could become a therapeutic target for IS (5). The 
results from a retrospective analysis by perfusion CT 
Patients
Patients with normal values Patients with increased values Patients with decreased values
n % n % n %
males 47 36.43 77 59.69 5 3.88
females 55 42.64 71 55.04 3 2.32
total 102 39.54 148 57.36 8 3.10








preceding diabetes mellitus 1 0.733 0.431
newly-diagnosed diabetes mellitus 0.733 1 0.535
blood glucose 0.431 0.535 1
Table 4. Correlations between admission blood glucose values, preceding and newly-diagnosed type 2 diabetes mellitus 













Table 5. Mean blood glucose values of adult AIS patients 
according to the number of accompanying CVDs
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of 26 patients suggests that chronic hyperglycaemia 
might be linked with cerebral microvascular 
remodeling in man (6). A randomized, blinded ef-
ficacy trial outlines the potential benefits and risks 
of standard versus intensive hyperglycaemia man-
agement in AIS patients (7). The detrimental effects 
of hyperglycaemia on the morbidity and mortality of 
AIS patients during the initial 48 hours of the disease 
were emphasized (8). A study of 2 639 IS patients in 
China shows that impaired glucose regulation as as-
sessed by the glucose tolerance test is an independent 
risk factor for their one-year mortality (p=0.006) 
and should be highlighted and intervened actively in 
such patients (9).
Hyperglycaemia is commonly encountered in 
patients with or without diabetes mellitus in AIS. The 
evidence links it with neurotoxicity coupled with the 
failure of intensive glucose control regimens to im-
prove functional outcomes in AIS and suggests that 
novel approaches should be devised. Glycaemic vari-
ability was a proven predictor of prognosis in criti-
cally ill AIS patients (10).
Admission hyperglycaemia was very common 
in AIS patients and was related to worse progno-
sis in non-lacunar brain infarction. The association 
between hyperglycaemia and clinical outcome in 689 
consecutive lacunar AIS patients in a hospitalized 
Chinese population was investigated (11). Of them, 
159 (23%) presented with diabetes mellitus. In 
non-lacunar AIS, admission hyperglycaemia was 
independently associated with increased risk of 
poor outcome (p=0.0005) while in lacunar AIS, 
it was not related to functional outcome at one 
year (p=0.086) irrespective of the diabetic status. 
Chronic hyperglycemia aggravated haemorrhagic 
transformation after stroke through mitochondrial 
dysfunction and morphological alteration (12).
The prevalence of prediabetes mellitus, an in-
termediate metabolic state between normal glucose 
metabolism and diabetes mellitus, in previously non-
diabetic patients with a recent AIS ranges from 23 to 
53% and represents undiagnosed abnormal glucose 
metabolism. This pathology seems to be a modest 
predictor for AIS, but doubles the risk for recurrent 
disease. It could become one of the most important 
modifiable therapeutic targets in both primary and 
secondary prevention (13).
The retrospective analysis of a prospective series 
of first-ever AIS patients revealed that the patients 
with prediabetes mellitus presented more common-
ly with arterial hypertension (p=0.006) and higher 
waist circumference (p<0.0001) than those without 
diabetes mellitus, and diabetes mellitus patients had 
more hypercholesterolemia (p<0.0001), coronary ar-
tery disease (p=0.005) and higher body mass index 
(p=0.017) than those with prediabetes (14). 
The investigation of 1 316 AIS patients with-
out previous diabetes mellitus in China demonstrat-
ed that the combination of glycated hemoglobin and 
fasting plasma glucose increased the diagnostic rate 
of diabetes mellitus when compared with oral glu-
cose tolerance test as well as with glycated hemo-
globin or fasting plasma glucose alone. The glycat-
ed hemoglobin could significantly detect more cas-
es of prediabetes than the oral glucose tolerance test 
(p<0.001) (15). The glycated hemoglobin ≥7.2% (>55 
mmol/mol) was an independent risk predictor for 
one-year all-cause mortality after first-ever AIS (16). 
Among 1052 AIS patients without diabetes mel-
litus, hazard ratio for AIS was 1.04 (95% CI 0.83-1.30) 
for the lowest glycated hemoglobin quartile (<6.35%) 
and 1.63 (95% CI 1.33-2.00) for the highest quartile 
(>7.70%) (for trend, p<0.001) while in 11 176  AIS pa-
tients with diabetes mellitus, it was 1.17 (95% CI 1.09-
1.26) for every 1% increment in glycated hemoglobin 
level (17).
In 140 out of 242 consecutive AIS patients 
without previously diagnosed diabetes mellitus, the 
disease was proved by means of glucose tolerance 
test at admission (18). In multivariate analysis, 
the risk of early neurological deterioration was 
significantly higher in these patients than in those 
with normal glucose tolerance (p=0.019) while the 
risk of poor outcome was more significantly high-
er (p<0.001), even after adjusting for confounding 
factors (p=0.008). 
In a population-based study in Greater 
Cincinnati/Northern Kentucky region, a rising inci-
dence of the history of diabetes mellitus among first 
IS patients - from 28% in 1993/1994 to 29% in 1999 
and 33% in 2005 was reported (19). Risk ratios for 
rates of IS among the patients with versus without 
diabetes mellitus for blacks reduced significantly 
from 5.6 in 1993/1994 to 3.2 in 2005. They varied 
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with age, with an overall 5- to 14-fold increased risk 
among the patients aged 20 to 65 years. Diabetes 
mellitus or impaired fasting glucose in young AIS 
survivors was frequent and was associated with 
recurrent vascular events. Regular screening yielded 
potential for secondary AIS prevention (20). Type 2 
diabetes mellitus was present in 32.2% of 482 AIS pa-
tients at a mean age of 78.8±6.7 years (21). AIS pa-
tients with diabetes mellitus should not be exclud-
ed from intravenous thrombolysis as it was indepen-
dently associated with a lower risk of poor outcome 
in such patients (p=0.002) (22).
CONCLUSION
The results from the present study and the 
recent literature data available illustrate the effect of 
the common disorders of glucose metabolism such 
as hyperglycaemia, prediabetes and diabetes mellitus 
on the development of AIS in adult patients. We 
could draw the conclusion that the regular control 
of blood glucose by the general practitioners and the 
promotion of the healthy life-style in CVD patients 
could successfully contribute to the prevention of 
AIS in Bulgaria.
REFERENCES
1. Palacio S, McClure LA, Benavente OR, Bazan 
C 3rd, Pergola P, Hart RG. Lacunar strokes in 
patients with diabetes mellitus: risk factors, infarct 
location, and prognosis: the secondary prevention 
of small subcortical strokes study. Stroke. 
2014;45(9):2689-94.
2. Hill MD. Stroke and diabetes mellitus. Handb Clin 
Neurol. 2014;126:167-74. 
3. Shindo A, Tomimoto H. Diabetes and ischemic 
stroke. Brain Nerve. 2014;66(2):107-19. Japanese.
4. Yoo DS, Chang J, Kim JT, Choi MJ, Choi J, Choi 
KH, et al. Various blood glucose parameters 
that indicate hyperglycemia after intravenous 
thrombolysis in acute ischemic stroke could predict 
worse outcome. PLoS One. 2014;9(4):e94364. doi: 
10.1371/journal.pone.0094364. 
5. Zhang S, Zuo W, Guo XF, He WB, Chen NH. 
Cerebral glucose transporter: the possible 
therapeutic target for ischemic stroke. Neurochem 
Int. 2014;70:22-9. 
6. Hou Q, Zuo Z, Michel P, Zhang Y, Eskandari A, 
Man F, et al. Influence of chronic hyperglycemia 
on cerebral microvascular remodeling: an in vivo 
study using perfusion computed tomography 
in acute ischemic stroke patients. Stroke. 
2013;44(12):3557-60. 
7. Bruno A, Durkalski VL, Hall CE, Juneja R, Barsan 
WG, Janis S, et al.; SHINE investigators. The Stroke 
Hyperglycemia Insulin Network Effort (SHINE) 
trial protocol: a randomized, blinded, efficacy 
trial of standard vs. intensive hyperglycemia 
management in acute stroke. Int J Stroke. 
2014;9(2):246-51. 
8. Clark ME, Payton JE, Pittiglio LI. Acute ischemic 
stroke and hyperglycemia. Crit Care Nurs Q. 
2014;37(2):182-7. 
9. Jia Q, Liu G, Zheng H, Zhao X, Wang C, Wang Y, 
et al.; Investigators for the Survey on Abnormal 
Glucose Regulation in Patients With Acute Stroke 
Across China. Impaired glucose regulation 
predicted 1-year mortality of Chinese patients 
with ischemic stroke: data from abnormal glucose 
regulation in patients with acute stroke across 
China. Stroke. 2014;45(5):1498-500.
10. González-Moreno EI, Cámara-Lemarroy CR, 
González-González JG, Góngora-Rivera F. 
Glycemic variability and acute ischemic stroke: the 
missing link? Transl Stroke Res. 2014;5(6):638-46. 
11. Fang Y, Zhang S, Wu B, Liu M. Hyperglycaemia 
in acute lacunar stroke: a Chinese hospital-based 
study. Diab Vasc Dis Res. 2013;10(3):216-21. 
12. Mishiro K, Imai T, Sugitani S, Kitashoji A, Suzuki 
Y, Takagi T, et al. Diabetes mellitus aggravates 
hemorrhagic transformation after ischemic stroke 
via mitochondrial defects leading to endothelial 
apoptosis. PLoS One. 2014;9(8):e103818. doi: 
10.1371/journal.pone.0103818.
13. Fonville S, Zandbergen AA, Koudstaal PJ, den 
Hertog HM. Prediabetes in patients with stroke 
or transient ischemic attack: prevalence, risk 
and clinical management. Cerebrovasc Dis. 
2014;37(6):393-400. 
14. Roquer J, Rodríguez-Campello A, Cuadrado-Godia 
E, Giralt-Steinhauer E, Jiménez-Conde J, Dégano 
IR, et al. Ischemic stroke in prediabetic patients. J 
Neurol. 2014;261(10):1866-70. 
15. Wu S, Shi Y, Pan Y, Li J, Jia Q, Zhang N, et 
al. Glycated hemoglobin independently or in 
combination with fasting plasma glucose versus 
oral glucose tolerance test to detect abnormal 
glycometabolism in acute ischemic stroke: a 
42  Scripta Scientifica Medica, vol. 47, No 2, 2015, pp. 37-42
Copyright © Medical University of Varna
Disorders of blood glucose levels in adult patients with acute ischemic stroke
Chinese cross-sectional study. BMC Neurol. 
2014;14:177. doi: 10.1186/s12883-014-0177-0.
16. Wu S, Wang C, Jia Q, Liu G, Hoff K, Wang X, et 
al. HbA1c is associated with increased all-cause 
mortality in the first year after acute ischemic 
stroke. Neurol Res. 2014a;36(5):444-52.
17. Khoury JC, Kleindorfer D, Alwell K, Moomaw 
CJ, Woo D, Adeoye O, et al. Diabetes mellitus: a 
risk factor for ischemic stroke in a large biracial 
population. Stroke. 2013;44(6):1500-4. 
18. Saliba W, Barnett-Griness O, Elias M, Rennert 
G. Glycated hemoglobin and risk of first episode 
stroke in diabetic patients with atrial fibrillation: A 
cohort study. Heart Rhythm. 2015;12(5):886-92.
19. Tanaka R, Ueno Y, Miyamoto N, Yamashiro K, 
Tanaka Y, Shimura H, et al. Impact of diabetes 
and prediabetes on the short-term prognosis in 
patients with acute ischemic stroke. J Neurol Sci. 
2013;332(1-2):45-50.
20. Khoury JC, Kleindorfer D, Alwell K, Moomaw CJ, 
Woo D, Adeoye O, Flaherty ML, et al. Diabetes 
mellitus: a risk factor for ischemic stroke in a large 
biracial population. Stroke. 2013;44(6):1500-4.
21. Rutten-Jacobs LC, Keurlings PA, Arntz RM, 
Maaijwee NA, Schoonderwaldt HC, Dorresteijn 
LD, et al. High incidence of diabetes after stroke in 
young adults and risk of recurrent vascular events: 
the FUTURE study. PLoS One. 2014;9(1):e87171. 
doi: 10.1371/journal.pone.0087171. 
22. Tziomalos K, Spanou M, Bouziana SD, Papado-
poulou M, Giampatzis V, Kostaki S, et al. Type 
2 diabetes is associated with a worse function-
al outcome of ischemic stroke. World J Diabetes. 
2014;5(6):939-44. 
23. Fuentes B, Masjuan J, Alonso de Leciñana M, Simal 
P, Egido J, Díaz-Otero F, et al.; Madrid Stroke 
Network. Benefits of intravenous thrombolysis 
in acute ischemic stroke related to extracranial 
internal carotid dissection. Dream or reality? Int J 
Stroke. 2012;7(1):7-13.
